Warning! GuruFocus detected
5 Severe warning signs
with 8YY.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Biolidics Ltd
NAICS : 621511
SIC : 8071
ISIN : SGXE89830751
Share Class Description:
SGX:8YY: Ordinary SharesDescription
Biolidics Ltd is engaged in technology development, technology transfer, marketing, sale and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are; Cancer, Infectious diseases, Laboratory services, and Corporate. The majority of the company's revenue is generated from the laboratory services segment which involves the business, operation, and provision of laboratory services to customers. Its operations are spread across Singapore, Japan, China, Europe, the United States, Hong Kong, the Philippines, Indonesia, and Others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.44 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -20.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -51.9 | |||||
| 3-Year EBITDA Growth Rate | 43.9 | |||||
| 3-Year EPS without NRI Growth Rate | 49.3 | |||||
| 3-Year FCF Growth Rate | 63.2 | |||||
| 3-Year Book Growth Rate | -50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.26 | |||||
| 9-Day RSI | 53.78 | |||||
| 14-Day RSI | 51.48 | |||||
| 3-1 Month Momentum % | -14.81 | |||||
| 6-1 Month Momentum % | 155.56 | |||||
| 12-1 Month Momentum % | 130 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.26 | |||||
| Quick Ratio | 0.26 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 40.08 | |||||
| Days Sales Outstanding | 40.35 | |||||
| Days Payable | 28.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -82 | |||||
| Shareholder Yield % | 0.44 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.63 | |||||
| Operating Margin % | -240.53 | |||||
| Net Margin % | -443.84 | |||||
| FCF Margin % | -87.04 | |||||
| ROA % | -273.49 | |||||
| ROIC % | -85.04 | |||||
| 3-Year ROIIC % | -48.64 | |||||
| ROC (Joel Greenblatt) % | -2441.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 24 | |||||
| PB Ratio | 24 | |||||
| EV-to-EBIT | -12.3 | |||||
| EV-to-EBITDA | -12.77 | |||||
| EV-to-Revenue | 52.04 | |||||
| EV-to-FCF | -57.32 | |||||
| Price-to-GF-Value | 2.4 | |||||
| Earnings Yield (Greenblatt) % | -8.13 | |||||
| FCF Yield % | -1.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biolidics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil S$) | 0.787 | ||
| EPS (TTM) (S$) | -0.005 | ||
| Beta | 2.77 | ||
| 3-Year Sharpe Ratio | -0.34 | ||
| 3-Year Sortino Ratio | -0.66 | ||
| Volatility % | 134.83 | ||
| 14-Day RSI | 51.48 | ||
| 14-Day ATR (S$) | 0.000864 | ||
| 20-Day SMA (S$) | 0.023 | ||
| 12-1 Month Momentum % | 130 | ||
| 52-Week Range (S$) | 0.008 - 0.033 | ||
| Shares Outstanding (Mil) | 1,690.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biolidics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biolidics Ltd Stock Events
| Event | Date | Price (S$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biolidics Ltd Frequently Asked Questions
What is Biolidics Ltd(SGX:8YY)'s stock price today?
The current price of SGX:8YY is S$0.02. The 52 week high of SGX:8YY is S$0.03 and 52 week low is S$0.01.
When is next earnings date of Biolidics Ltd(SGX:8YY)?
The next earnings date of Biolidics Ltd(SGX:8YY) is .
Does Biolidics Ltd(SGX:8YY) pay dividends? If so, how much?
Biolidics Ltd(SGX:8YY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers